Public Warnings On Recalls: US FDA Clarifies Rules
Executive Summary
A new draft guidance document discusses what the agency expects to see in public warnings issued in conjunction with product recalls.
You may also be interested in...
Total Recall: FDA Final Guidance Says Firms Should Publicize Recalls Until Problem Products No Longer Used
Recall announcements should be readily accessible to the public until recalled products are gone from the market, US FDA recommends in a new corrections and removals guidance that covers all goods regulated by the agency.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.